SEATTLE, July 22, 2021, (MEDGADGET) — Global Microneedle Flu Vaccine Market Analysis
Global Microneedle Flu Vaccine Market, by Product Type (Dissolving Microneedle, Solid Microneedle, Coated Microneedle, and Hollow Microneedle), by Vaccine Type (Quadrivalent Flu Vaccine and Trivalent Flu Vaccine), by Flu Type (Influenza B and Influenza A (H3N1 and H1N1)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is projected to reach US$ 1,322.1 million in 2020 and is forecast to grow at a CAGR of 6.1 percent over the forecast period (2020-2027), as mentioned in a new report published by Coherent Market Insights.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-pdf/2286
To retain a competitive advantage in the industry, key corporations are concentrating on various techniques such as collaborations and partnerships. 3M Company, Inc. agreed to sell its medicine delivery business to Altaris Capital Partners, LLC in December 2019. Altaris Capital Partners, LLC will invest US$ 650 million in 3M Company as part of this arrangement. The arrangement will help in the development of the drug delivery industry and the production of pharmaceutical goods employing cutting-edge inhalation, epidermal, microneedle, and traditional drug delivery methods.
Impact of COVID-19 Pandemic
The COVID-19 outbreak has impacted various markets throughout the world, and it is predicted to stymie raw material supplies for microneedle flu vaccine product development. Furthermore, the COVID-19 pandemic has had a three-fold influence on the worldwide micro-needle flu vaccine market: directly impacting production and demand; disrupting distribution routes; and 3) having a financial impact on enterprises and financial markets. Due to widespread lockdowns, supply chains and manufacturing activity in India, China, and the U.S. have been interrupted. Nations such as Saudi Arabia, the United Arab Emirates, Egypt, and others, on the other hand, are having difficulties transporting pharmaceuticals from one location to another.
In addition, research institutions are concentrating their efforts on creating a micro-needle coronavirus vaccination for the prevention of COVID-19 infections. Researchers at the University of Pittsburgh are working on developing a micro-needle vaccination that targets the peak antigen of the SARS-CoV-2 coronavirus in April 2020. The National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the National Cancer Institute all contributed to the research (NCI).
Browse 35 Market Data Tables and 32Figures spread through 193 Pages and in-depth TOC on “Global Microneedle Flu Vaccine Market, by Product Type (Dissolving Microneedle, Solid Microneedle, Coated Microneedle, and Hollow Microneedle), by Vaccine Type (Quadrivalent Flu Vaccine and Trivalent Flu Vaccine), by Flu Type (Influenza B and Influenza A (H3N1 and H1N1)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa”
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/microneedle-flu-vaccine-market-3527
Market companies are concentrating on innovative tactics such as mergers and acquisitions to enhance their position in the global microneedle flu vaccine market, and the market is projected to develop significantly over the forecast period. Vetter Pharma International USA, Inc and Microdermics Inc merged in 2017 to create a new micro-needle medication delivery method for influenza and other diseases.
Key Takeaways
The global microneedle flu vaccine market is estimated to display a CAGR of 6.1 percent during the forecast period, as prominent businesses are concentrating on inorganic tactics in the market. In August 2018, BioNTech and Pfizer established a cooperation for developing vaccines for protection of influenza based on messenger RNA. BioNTech was in charge of performing the vaccine’s initial research study, while Pfizer was in charge of medical development and marketing.
Solid microneedles are expected to have the largest market share in 2020, thanks to prominent manufacturers like 3M offering solid microneedle technology, which uses small needles affixed on clothing patches to administer vaccinations.
Due to rising demand for Fluzone High-Dose quadrivalent vaccination for influenza treatment, the Quadrivalent Flu vaccine in North America is projected to account for the majority of market share in 2020.
Influenza is the most common kind of flu. Due to the increased incidence and severity of H3N2 illness, the segment is expected to account for a significant portion of the market in 2020.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2286
Competitive Landscape
Major companies contributing in the global microneedle flu vaccine market are Becton, Corium International, Inc, NanoPass Technologies Limited, 3M Company, GC Pharma, Sanofi S.A., OraSure Technologies, Inc., Debiotech S.A, Microdermics, CosMED Pharmaceuticals Co., Ltd, FluGen, Inc, and Dickinson and Company.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Flu Type
- Market Snapshot, By Region
- Market Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Drivers
- Restraint
- Opportunity
- Impact Analysis
- Epidemiology
- Pipeline Analysis – Influenza Vaccine
- List of Marketed Microneedles
- Developments of Microneedles
- Key Highlights
- PEST Analysis
- Acquisition and Collaboration Scenario
- Market Trends
- Regulatory Scenario
- Recent Advancements in Microneedle Flu Vaccine
- Influenza Vaccination Rate
- Demand for Influenza Vaccine – Taiwan
- Suppliers of Influenza Vaccine
- Brand Analysis
- Global Microneedle Flu Vaccine Market, Impact of COVID-19 Pandemic
- COVID-19 Epidemiology
- COVID-19 Impact on the Overall Healthcare Market
- Government Initiatives to Combat Seasonal Influenza Amid COVID-19
- Government Initiatives to Combat COVID-19
- Demand & Supply Impact
- Global Microneedle Flu Vaccine Market, By Product Type , 2016-2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Solid Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Hollow Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Coated Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Dissolving Microneedles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Solid Microneedles
- Introduction
- Global Microneedle Flu Vaccine Market, By Vaccine Type , 2016-2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Trivalent Flu Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Quadrivalent Flu Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Trivalent Flu Vaccine
- Introduction
- Global Microneedle Flu Vaccine Market, By Flu Type, 2016–2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Influenza A
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- H1N1
- H3N2
- Influenza B
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
- Influenza A
- Introduction
- Global Microneedle Flu Vaccine Market, By Region, 2016–2027 (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Countries, 2017–2027
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Vaccine Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Flu Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Vaccine Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Flu Type, 2016–2027 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Vaccine Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Flu Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Vaccine Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Flu Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Vaccine Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Flu Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Country, 2016–2027 (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Vaccine Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Flu Type, 2016–2027 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016–2027 (US$ Bn)
- South Africa
- Central Africa
- North Africa
- Introduction
-
- Company Profiles
- Competitive Landscape
- Vaccine Companies
Have a Look at Related Research Insights:
Cell And Tissue Culture Supplies Market To Reach US$ 53,065.9 Million By 2027
Coronavirus Vaccine Market To Surpass US$ 95,988.0 Million By 2028
Plant-Based Vaccines Market To Surpass US$ 584.1 Million By 2028
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837